Skip to main content
Equibles
PFE logo

PFE · Pfizer Inc · Metrics

Track PFE — free

Use PFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$30.03 -0.39 (-1.28%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$171.16B
Shares
5.70B
Volume · Oct 23 29.48M Avg daily vol (3M) 34.46M

PFE metrics

103 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$30.03
Market cap
$171.16B

Price action

20 metrics
Price change (1W)
+1.5%
Price change (30D)
+4.7%
Price change (3M)
+22.4%
Price change (6M)
+11.2%
Price change (YTD)
+20.6%
Price change (1Y)
+21.7%
Trailing year
Price change (5Y)
-30.4%
52-week high
$30.42
52-week low
$23.67
Change from 52-week high
-1.3%
Change from 52-week low
+26.9%
Annualized volatility
21.6%
Annualized volatility (3M)
20.0%
Beta
0.3
RSI (14D)
65.5
Price vs SMA 50
+6.1%
Price vs SMA 200
+12.5%
Avg volume (3M)
34.46M
Relative volume
0.9
Average dollar volume
$949.29M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
5.70B

Valuation

12 metrics
P / E (TTM)
39.5
Trailing earnings · reciprocal yield 2.5%
PEG ratio
—
EV / revenue
3.7×
reciprocal yield 27.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.7×
reciprocal yield 37.2%
P / book
2.0
reciprocal yield 49.8%
FCF yield
6.4%
TTM · current market cap
Buyback yield
0.0%
P / FCF
15.6
reciprocal yield 6.4%
P / operating cash flow
12.8
reciprocal yield 7.8%
Earnings yield
2.5%

Historical valuation

8 metrics
P / E historical average (3Y)
25.0×
reciprocal yield 4.0%
P / E historical average (5Y)
19.3×
reciprocal yield 5.2%
EV / revenue historical average (3Y)
3.5×
reciprocal yield 28.4%
EV / revenue historical average (5Y)
3.5×
reciprocal yield 28.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
5.7%
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
$1.72
Dividend growth YoY
+0.6%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-07-24

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
73.2%
Operating margin
—
Trailing 12 months
Net margin
6.8%
Gross profit (TTM)
$46.61B
Operating profit (TTM)
—
Net income (TTM)
$4.33B
Trailing 12 months
Diluted EPS (TTM)
$0.76
FCF margin
17.2%
Effective tax rate
-3.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$11.14
Gross profit per diluted share (TTM)
$8.15
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.76
Operating cash flow per diluted share (TTM)
$2.34
Free cash flow per diluted share (TTM)
$1.92
Capital expenditures per diluted share (TTM)
$0.42
R&D per diluted share (TTM)
$1.93
Stock compensation per diluted share (TTM)
$0.17
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+2.6%
Year over year
Net income growth YoY
-108.5%
Revenue (TTM)
$63.70B
Trailing 12 months
EPS growth YoY
-107.8%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-14.8%
Revenue CAGR (5Y)
+8.5%
EPS CAGR (3Y)
-37.1%
EPS CAGR (5Y)
-3.6%
FCF CAGR (3Y)
-29.6%
FCF CAGR (5Y)
-5.7%

Quality

14 metrics
Return on equity
5.1%
Return on assets
2.2%
Debt / equity
0.7
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
$10.98B
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$62.22B
Latest balance sheet
Cash & equivalents
$976.00M
Total assets
$201.13B
Total debt
$63.19B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.40B
Capital expenditures (TTM)
$2.42B
R&D (TTM)
$11.05B
SG&A (TTM)
$13.72B
Stock compensation (TTM)
$947.00M
R&D / revenue
17.3%
Stock compensation / revenue
1.5%

Ownership (13F)

9 metrics
13F filers
2,861
13F filer change QoQ
-128
Institutional ownership
70.1%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
7.5%
Private-fund adviser ownership
6.9%
Active holders' share change QoQ
-3.4%
Holder tenure
18.6
Price vs estimated holder cost
-12.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.6%

Short interest

3 metrics
Short interest
2.6%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
$2.88M
Insider-sentiment score
86 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 78003 CUSIP 717081103 13F (30d) 927 filings 890 filers Visit website Investor relations